nodes	percent_of_prediction	percent_of_DWPC	metapath
Gefitinib—ABCG2—primary biliary cirrhosis	0.38	0.696	CbGaD
Gefitinib—ALB—primary biliary cirrhosis	0.166	0.304	CbGaD
Gefitinib—CYP3A4—Chenodeoxycholic acid—primary biliary cirrhosis	0.0372	0.311	CbGbCtD
Gefitinib—CYP2C9—Colchicine—primary biliary cirrhosis	0.0323	0.27	CbGbCtD
Gefitinib—ABCB1—Colchicine—primary biliary cirrhosis	0.0314	0.262	CbGbCtD
Gefitinib—CYP3A4—Colchicine—primary biliary cirrhosis	0.0188	0.157	CbGbCtD
Gefitinib—ORM1—bile—primary biliary cirrhosis	0.00778	0.231	CbGeAlD
Gefitinib—Appetite absent—Colchicine—primary biliary cirrhosis	0.00411	0.0251	CcSEcCtD
Gefitinib—Interstitial pneumonia—Ursodeoxycholic acid—primary biliary cirrhosis	0.0038	0.0232	CcSEcCtD
Gefitinib—Interstitial pneumonia—Chenodeoxycholic acid—primary biliary cirrhosis	0.0038	0.0232	CcSEcCtD
Gefitinib—Gastric ulcer—Chenodeoxycholic acid—primary biliary cirrhosis	0.00316	0.0193	CcSEcCtD
Gefitinib—Gastric ulcer—Ursodeoxycholic acid—primary biliary cirrhosis	0.00316	0.0193	CcSEcCtD
Gefitinib—Interstitial lung disease—Chenodeoxycholic acid—primary biliary cirrhosis	0.0026	0.0159	CcSEcCtD
Gefitinib—Interstitial lung disease—Ursodeoxycholic acid—primary biliary cirrhosis	0.0026	0.0159	CcSEcCtD
Gefitinib—Pleural effusion—Chenodeoxycholic acid—primary biliary cirrhosis	0.0024	0.0147	CcSEcCtD
Gefitinib—Pleural effusion—Ursodeoxycholic acid—primary biliary cirrhosis	0.0024	0.0147	CcSEcCtD
Gefitinib—Amblyopia—Ursodeoxycholic acid—primary biliary cirrhosis	0.00238	0.0145	CcSEcCtD
Gefitinib—Amblyopia—Chenodeoxycholic acid—primary biliary cirrhosis	0.00238	0.0145	CcSEcCtD
Gefitinib—Acne—Ursodeoxycholic acid—primary biliary cirrhosis	0.00219	0.0133	CcSEcCtD
Gefitinib—Acne—Chenodeoxycholic acid—primary biliary cirrhosis	0.00219	0.0133	CcSEcCtD
Gefitinib—ORM1—gall bladder—primary biliary cirrhosis	0.00216	0.0642	CbGeAlD
Gefitinib—Bosutinib—RPS6KB1—primary biliary cirrhosis	0.00214	0.389	CrCbGaD
Gefitinib—ERBB3—epithelium—primary biliary cirrhosis	0.00199	0.0592	CbGeAlD
Gefitinib—Drug interaction—Ursodeoxycholic acid—primary biliary cirrhosis	0.00198	0.0121	CcSEcCtD
Gefitinib—Drug interaction—Chenodeoxycholic acid—primary biliary cirrhosis	0.00198	0.0121	CcSEcCtD
Gefitinib—MKNK2—epithelium—primary biliary cirrhosis	0.0019	0.0563	CbGeAlD
Gefitinib—ALB—gall bladder—primary biliary cirrhosis	0.00189	0.0563	CbGeAlD
Gefitinib—Bladder pain—Colchicine—primary biliary cirrhosis	0.00185	0.0113	CcSEcCtD
Gefitinib—MKNK2—smooth muscle tissue—primary biliary cirrhosis	0.00183	0.0542	CbGeAlD
Gefitinib—IRAK1—smooth muscle tissue—primary biliary cirrhosis	0.00183	0.0542	CbGeAlD
Gefitinib—Melaena—Ursodeoxycholic acid—primary biliary cirrhosis	0.0018	0.011	CcSEcCtD
Gefitinib—Cystitis noninfective—Chenodeoxycholic acid—primary biliary cirrhosis	0.0018	0.011	CcSEcCtD
Gefitinib—Cystitis noninfective—Ursodeoxycholic acid—primary biliary cirrhosis	0.0018	0.011	CcSEcCtD
Gefitinib—Melaena—Chenodeoxycholic acid—primary biliary cirrhosis	0.0018	0.011	CcSEcCtD
Gefitinib—Cystitis—Ursodeoxycholic acid—primary biliary cirrhosis	0.00178	0.0108	CcSEcCtD
Gefitinib—Cystitis—Chenodeoxycholic acid—primary biliary cirrhosis	0.00178	0.0108	CcSEcCtD
Gefitinib—Bladder pain—Chenodeoxycholic acid—primary biliary cirrhosis	0.00166	0.0101	CcSEcCtD
Gefitinib—Bladder pain—Ursodeoxycholic acid—primary biliary cirrhosis	0.00166	0.0101	CcSEcCtD
Gefitinib—Atrial fibrillation—Chenodeoxycholic acid—primary biliary cirrhosis	0.00141	0.0086	CcSEcCtD
Gefitinib—Atrial fibrillation—Ursodeoxycholic acid—primary biliary cirrhosis	0.00141	0.0086	CcSEcCtD
Gefitinib—Dehydration—Colchicine—primary biliary cirrhosis	0.00138	0.00843	CcSEcCtD
Gefitinib—Aspartate aminotransferase increased—Colchicine—primary biliary cirrhosis	0.00134	0.00816	CcSEcCtD
Gefitinib—Alanine aminotransferase increased—Colchicine—primary biliary cirrhosis	0.00131	0.008	CcSEcCtD
Gefitinib—Afatinib—ABCG2—primary biliary cirrhosis	0.00125	0.228	CrCbGaD
Gefitinib—Dehydration—Chenodeoxycholic acid—primary biliary cirrhosis	0.00124	0.00758	CcSEcCtD
Gefitinib—Dehydration—Ursodeoxycholic acid—primary biliary cirrhosis	0.00124	0.00758	CcSEcCtD
Gefitinib—EGFR—liver—primary biliary cirrhosis	0.00122	0.0362	CbGeAlD
Gefitinib—Aspartate aminotransferase increased—Ursodeoxycholic acid—primary biliary cirrhosis	0.0012	0.00734	CcSEcCtD
Gefitinib—Aspartate aminotransferase increased—Chenodeoxycholic acid—primary biliary cirrhosis	0.0012	0.00734	CcSEcCtD
Gefitinib—Alanine aminotransferase increased—Chenodeoxycholic acid—primary biliary cirrhosis	0.00118	0.00718	CcSEcCtD
Gefitinib—Alanine aminotransferase increased—Ursodeoxycholic acid—primary biliary cirrhosis	0.00118	0.00718	CcSEcCtD
Gefitinib—CSNK1E—liver—primary biliary cirrhosis	0.00117	0.0348	CbGeAlD
Gefitinib—IRAK4—liver—primary biliary cirrhosis	0.00115	0.0342	CbGeAlD
Gefitinib—Pancreatitis—Ursodeoxycholic acid—primary biliary cirrhosis	0.00113	0.0069	CcSEcCtD
Gefitinib—Pancreatitis—Chenodeoxycholic acid—primary biliary cirrhosis	0.00113	0.0069	CcSEcCtD
Gefitinib—ERBB3—liver—primary biliary cirrhosis	0.00113	0.0336	CbGeAlD
Gefitinib—Stomatitis—Colchicine—primary biliary cirrhosis	0.00112	0.00681	CcSEcCtD
Gefitinib—Haematuria—Colchicine—primary biliary cirrhosis	0.00109	0.00666	CcSEcCtD
Gefitinib—IRAK1—liver—primary biliary cirrhosis	0.00107	0.0319	CbGeAlD
Gefitinib—MKNK2—liver—primary biliary cirrhosis	0.00107	0.0319	CbGeAlD
Gefitinib—MKNK1—liver—primary biliary cirrhosis	0.00106	0.0315	CbGeAlD
Gefitinib—Weight decreased—Ursodeoxycholic acid—primary biliary cirrhosis	0.00104	0.00637	CcSEcCtD
Gefitinib—Weight decreased—Chenodeoxycholic acid—primary biliary cirrhosis	0.00104	0.00637	CcSEcCtD
Gefitinib—Pneumonia—Chenodeoxycholic acid—primary biliary cirrhosis	0.00103	0.00631	CcSEcCtD
Gefitinib—Pneumonia—Ursodeoxycholic acid—primary biliary cirrhosis	0.00103	0.00631	CcSEcCtD
Gefitinib—Infestation NOS—Ursodeoxycholic acid—primary biliary cirrhosis	0.00103	0.00628	CcSEcCtD
Gefitinib—Infestation—Ursodeoxycholic acid—primary biliary cirrhosis	0.00103	0.00628	CcSEcCtD
Gefitinib—Infestation NOS—Chenodeoxycholic acid—primary biliary cirrhosis	0.00103	0.00628	CcSEcCtD
Gefitinib—Infestation—Chenodeoxycholic acid—primary biliary cirrhosis	0.00103	0.00628	CcSEcCtD
Gefitinib—Conjunctivitis—Ursodeoxycholic acid—primary biliary cirrhosis	0.001	0.0061	CcSEcCtD
Gefitinib—Conjunctivitis—Chenodeoxycholic acid—primary biliary cirrhosis	0.001	0.0061	CcSEcCtD
Gefitinib—Haematuria—Chenodeoxycholic acid—primary biliary cirrhosis	0.000981	0.00599	CcSEcCtD
Gefitinib—Haematuria—Ursodeoxycholic acid—primary biliary cirrhosis	0.000981	0.00599	CcSEcCtD
Gefitinib—Hepatobiliary disease—Ursodeoxycholic acid—primary biliary cirrhosis	0.000973	0.00594	CcSEcCtD
Gefitinib—Hepatobiliary disease—Chenodeoxycholic acid—primary biliary cirrhosis	0.000973	0.00594	CcSEcCtD
Gefitinib—Epistaxis—Chenodeoxycholic acid—primary biliary cirrhosis	0.00097	0.00592	CcSEcCtD
Gefitinib—Epistaxis—Ursodeoxycholic acid—primary biliary cirrhosis	0.00097	0.00592	CcSEcCtD
Gefitinib—Eye disorder—Colchicine—primary biliary cirrhosis	0.00096	0.00586	CcSEcCtD
Gefitinib—Haemoglobin—Chenodeoxycholic acid—primary biliary cirrhosis	0.000928	0.00566	CcSEcCtD
Gefitinib—Haemoglobin—Ursodeoxycholic acid—primary biliary cirrhosis	0.000928	0.00566	CcSEcCtD
Gefitinib—Mediastinal disorder—Colchicine—primary biliary cirrhosis	0.000926	0.00565	CcSEcCtD
Gefitinib—Haemorrhage—Chenodeoxycholic acid—primary biliary cirrhosis	0.000923	0.00564	CcSEcCtD
Gefitinib—Haemorrhage—Ursodeoxycholic acid—primary biliary cirrhosis	0.000923	0.00564	CcSEcCtD
Gefitinib—Urinary tract disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000912	0.00557	CcSEcCtD
Gefitinib—Urinary tract disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000912	0.00557	CcSEcCtD
Gefitinib—Oedema peripheral—Ursodeoxycholic acid—primary biliary cirrhosis	0.00091	0.00555	CcSEcCtD
Gefitinib—Oedema peripheral—Chenodeoxycholic acid—primary biliary cirrhosis	0.00091	0.00555	CcSEcCtD
Gefitinib—Alopecia—Colchicine—primary biliary cirrhosis	0.000908	0.00554	CcSEcCtD
Gefitinib—Urethral disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000905	0.00552	CcSEcCtD
Gefitinib—Urethral disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000905	0.00552	CcSEcCtD
Gefitinib—Malnutrition—Colchicine—primary biliary cirrhosis	0.000895	0.00546	CcSEcCtD
Gefitinib—Erlotinib—ABCG2—primary biliary cirrhosis	0.000886	0.161	CrCbGaD
Gefitinib—STK10—liver—primary biliary cirrhosis	0.000874	0.0259	CbGeAlD
Gefitinib—Eye disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000863	0.00527	CcSEcCtD
Gefitinib—Eye disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000863	0.00527	CcSEcCtD
Gefitinib—Cardiac disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000857	0.00523	CcSEcCtD
Gefitinib—Cardiac disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000857	0.00523	CcSEcCtD
Gefitinib—Angiopathy—Ursodeoxycholic acid—primary biliary cirrhosis	0.000838	0.00511	CcSEcCtD
Gefitinib—Angiopathy—Chenodeoxycholic acid—primary biliary cirrhosis	0.000838	0.00511	CcSEcCtD
Gefitinib—Mediastinal disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000832	0.00508	CcSEcCtD
Gefitinib—Mediastinal disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000832	0.00508	CcSEcCtD
Gefitinib—Anaemia—Colchicine—primary biliary cirrhosis	0.000827	0.00505	CcSEcCtD
Gefitinib—Arrhythmia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000825	0.00503	CcSEcCtD
Gefitinib—Arrhythmia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000825	0.00503	CcSEcCtD
Gefitinib—Angioedema—Colchicine—primary biliary cirrhosis	0.000817	0.00499	CcSEcCtD
Gefitinib—Alopecia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000816	0.00498	CcSEcCtD
Gefitinib—Alopecia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000816	0.00498	CcSEcCtD
Gefitinib—Malnutrition—Ursodeoxycholic acid—primary biliary cirrhosis	0.000804	0.00491	CcSEcCtD
Gefitinib—Malnutrition—Chenodeoxycholic acid—primary biliary cirrhosis	0.000804	0.00491	CcSEcCtD
Gefitinib—MAP2K5—liver—primary biliary cirrhosis	0.00078	0.0232	CbGeAlD
Gefitinib—Anaemia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000743	0.00453	CcSEcCtD
Gefitinib—Anaemia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000743	0.00453	CcSEcCtD
Gefitinib—Angioedema—Ursodeoxycholic acid—primary biliary cirrhosis	0.000734	0.00448	CcSEcCtD
Gefitinib—Angioedema—Chenodeoxycholic acid—primary biliary cirrhosis	0.000734	0.00448	CcSEcCtD
Gefitinib—Malaise—Ursodeoxycholic acid—primary biliary cirrhosis	0.000725	0.00442	CcSEcCtD
Gefitinib—Malaise—Chenodeoxycholic acid—primary biliary cirrhosis	0.000725	0.00442	CcSEcCtD
Gefitinib—Shock—Colchicine—primary biliary cirrhosis	0.000718	0.00438	CcSEcCtD
Gefitinib—Nervous system disorder—Colchicine—primary biliary cirrhosis	0.000716	0.00437	CcSEcCtD
Gefitinib—Thrombocytopenia—Colchicine—primary biliary cirrhosis	0.000715	0.00436	CcSEcCtD
Gefitinib—Skin disorder—Colchicine—primary biliary cirrhosis	0.000709	0.00433	CcSEcCtD
Gefitinib—Cough—Ursodeoxycholic acid—primary biliary cirrhosis	0.000701	0.00428	CcSEcCtD
Gefitinib—Cough—Chenodeoxycholic acid—primary biliary cirrhosis	0.000701	0.00428	CcSEcCtD
Gefitinib—Hypotension—Colchicine—primary biliary cirrhosis	0.000682	0.00416	CcSEcCtD
Gefitinib—Unspecified disorder of skin and subcutaneous tissue—Chenodeoxycholic acid—primary biliary cirrhosis	0.00068	0.00415	CcSEcCtD
Gefitinib—Unspecified disorder of skin and subcutaneous tissue—Ursodeoxycholic acid—primary biliary cirrhosis	0.00068	0.00415	CcSEcCtD
Gefitinib—Dry mouth—Chenodeoxycholic acid—primary biliary cirrhosis	0.000669	0.00408	CcSEcCtD
Gefitinib—Dry mouth—Ursodeoxycholic acid—primary biliary cirrhosis	0.000669	0.00408	CcSEcCtD
Gefitinib—Infection—Chenodeoxycholic acid—primary biliary cirrhosis	0.000652	0.00398	CcSEcCtD
Gefitinib—Infection—Ursodeoxycholic acid—primary biliary cirrhosis	0.000652	0.00398	CcSEcCtD
Gefitinib—Shock—Chenodeoxycholic acid—primary biliary cirrhosis	0.000645	0.00394	CcSEcCtD
Gefitinib—Shock—Ursodeoxycholic acid—primary biliary cirrhosis	0.000645	0.00394	CcSEcCtD
Gefitinib—Nervous system disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000643	0.00393	CcSEcCtD
Gefitinib—Nervous system disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000643	0.00393	CcSEcCtD
Gefitinib—Thrombocytopenia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000642	0.00392	CcSEcCtD
Gefitinib—Thrombocytopenia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000642	0.00392	CcSEcCtD
Gefitinib—Skin disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000637	0.00389	CcSEcCtD
Gefitinib—Skin disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000637	0.00389	CcSEcCtD
Gefitinib—CYP1A1—epithelium—primary biliary cirrhosis	0.000636	0.0189	CbGeAlD
Gefitinib—Decreased appetite—Colchicine—primary biliary cirrhosis	0.000635	0.00387	CcSEcCtD
Gefitinib—ORM1—liver—primary biliary cirrhosis	0.000633	0.0188	CbGeAlD
Gefitinib—Gastrointestinal disorder—Colchicine—primary biliary cirrhosis	0.00063	0.00385	CcSEcCtD
Gefitinib—Fatigue—Colchicine—primary biliary cirrhosis	0.000629	0.00384	CcSEcCtD
Gefitinib—Anorexia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000625	0.00382	CcSEcCtD
Gefitinib—Anorexia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000625	0.00382	CcSEcCtD
Gefitinib—Hypotension—Chenodeoxycholic acid—primary biliary cirrhosis	0.000613	0.00374	CcSEcCtD
Gefitinib—Hypotension—Ursodeoxycholic acid—primary biliary cirrhosis	0.000613	0.00374	CcSEcCtD
Gefitinib—Gastrointestinal pain—Colchicine—primary biliary cirrhosis	0.000597	0.00364	CcSEcCtD
Gefitinib—Dyspnoea—Chenodeoxycholic acid—primary biliary cirrhosis	0.000585	0.00357	CcSEcCtD
Gefitinib—Dyspnoea—Ursodeoxycholic acid—primary biliary cirrhosis	0.000585	0.00357	CcSEcCtD
Gefitinib—Vandetanib—ABCG2—primary biliary cirrhosis	0.000584	0.106	CrCbGaD
Gefitinib—Urticaria—Colchicine—primary biliary cirrhosis	0.00058	0.00354	CcSEcCtD
Gefitinib—Abdominal pain—Colchicine—primary biliary cirrhosis	0.000577	0.00352	CcSEcCtD
Gefitinib—Decreased appetite—Ursodeoxycholic acid—primary biliary cirrhosis	0.00057	0.00348	CcSEcCtD
Gefitinib—Decreased appetite—Chenodeoxycholic acid—primary biliary cirrhosis	0.00057	0.00348	CcSEcCtD
Gefitinib—Gastrointestinal disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000566	0.00346	CcSEcCtD
Gefitinib—Gastrointestinal disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000566	0.00346	CcSEcCtD
Gefitinib—Fatigue—Ursodeoxycholic acid—primary biliary cirrhosis	0.000566	0.00345	CcSEcCtD
Gefitinib—Fatigue—Chenodeoxycholic acid—primary biliary cirrhosis	0.000566	0.00345	CcSEcCtD
Gefitinib—Pain—Ursodeoxycholic acid—primary biliary cirrhosis	0.000561	0.00342	CcSEcCtD
Gefitinib—Pain—Chenodeoxycholic acid—primary biliary cirrhosis	0.000561	0.00342	CcSEcCtD
Gefitinib—Constipation—Ursodeoxycholic acid—primary biliary cirrhosis	0.000561	0.00342	CcSEcCtD
Gefitinib—Constipation—Chenodeoxycholic acid—primary biliary cirrhosis	0.000561	0.00342	CcSEcCtD
Gefitinib—ALB—liver—primary biliary cirrhosis	0.000555	0.0165	CbGeAlD
Gefitinib—Hypersensitivity—Colchicine—primary biliary cirrhosis	0.000538	0.00328	CcSEcCtD
Gefitinib—Gastrointestinal pain—Ursodeoxycholic acid—primary biliary cirrhosis	0.000536	0.00327	CcSEcCtD
Gefitinib—Gastrointestinal pain—Chenodeoxycholic acid—primary biliary cirrhosis	0.000536	0.00327	CcSEcCtD
Gefitinib—Asthenia—Colchicine—primary biliary cirrhosis	0.000524	0.0032	CcSEcCtD
Gefitinib—Urticaria—Chenodeoxycholic acid—primary biliary cirrhosis	0.000521	0.00318	CcSEcCtD
Gefitinib—Urticaria—Ursodeoxycholic acid—primary biliary cirrhosis	0.000521	0.00318	CcSEcCtD
Gefitinib—Body temperature increased—Chenodeoxycholic acid—primary biliary cirrhosis	0.000519	0.00317	CcSEcCtD
Gefitinib—Abdominal pain—Chenodeoxycholic acid—primary biliary cirrhosis	0.000519	0.00317	CcSEcCtD
Gefitinib—Body temperature increased—Ursodeoxycholic acid—primary biliary cirrhosis	0.000519	0.00317	CcSEcCtD
Gefitinib—Abdominal pain—Ursodeoxycholic acid—primary biliary cirrhosis	0.000519	0.00317	CcSEcCtD
Gefitinib—Diarrhoea—Colchicine—primary biliary cirrhosis	0.0005	0.00305	CcSEcCtD
Gefitinib—Hypersensitivity—Ursodeoxycholic acid—primary biliary cirrhosis	0.000483	0.00295	CcSEcCtD
Gefitinib—Hypersensitivity—Chenodeoxycholic acid—primary biliary cirrhosis	0.000483	0.00295	CcSEcCtD
Gefitinib—Asthenia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000471	0.00287	CcSEcCtD
Gefitinib—Asthenia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000471	0.00287	CcSEcCtD
Gefitinib—Vomiting—Colchicine—primary biliary cirrhosis	0.000464	0.00283	CcSEcCtD
Gefitinib—Pruritus—Chenodeoxycholic acid—primary biliary cirrhosis	0.000464	0.00283	CcSEcCtD
Gefitinib—Pruritus—Ursodeoxycholic acid—primary biliary cirrhosis	0.000464	0.00283	CcSEcCtD
Gefitinib—Rash—Colchicine—primary biliary cirrhosis	0.00046	0.00281	CcSEcCtD
Gefitinib—Dermatitis—Colchicine—primary biliary cirrhosis	0.00046	0.00281	CcSEcCtD
Gefitinib—Diarrhoea—Chenodeoxycholic acid—primary biliary cirrhosis	0.000449	0.00274	CcSEcCtD
Gefitinib—Diarrhoea—Ursodeoxycholic acid—primary biliary cirrhosis	0.000449	0.00274	CcSEcCtD
Gefitinib—CYP2C19—liver—primary biliary cirrhosis	0.000447	0.0133	CbGeAlD
Gefitinib—Nausea—Colchicine—primary biliary cirrhosis	0.000434	0.00265	CcSEcCtD
Gefitinib—Vomiting—Chenodeoxycholic acid—primary biliary cirrhosis	0.000417	0.00255	CcSEcCtD
Gefitinib—Vomiting—Ursodeoxycholic acid—primary biliary cirrhosis	0.000417	0.00255	CcSEcCtD
Gefitinib—Rash—Ursodeoxycholic acid—primary biliary cirrhosis	0.000414	0.00252	CcSEcCtD
Gefitinib—Rash—Chenodeoxycholic acid—primary biliary cirrhosis	0.000414	0.00252	CcSEcCtD
Gefitinib—Dermatitis—Chenodeoxycholic acid—primary biliary cirrhosis	0.000413	0.00252	CcSEcCtD
Gefitinib—Dermatitis—Ursodeoxycholic acid—primary biliary cirrhosis	0.000413	0.00252	CcSEcCtD
Gefitinib—Nausea—Chenodeoxycholic acid—primary biliary cirrhosis	0.00039	0.00238	CcSEcCtD
Gefitinib—Nausea—Ursodeoxycholic acid—primary biliary cirrhosis	0.00039	0.00238	CcSEcCtD
Gefitinib—Erlotinib—ALB—primary biliary cirrhosis	0.000386	0.0702	CrCbGaD
Gefitinib—ABCG2—liver—primary biliary cirrhosis	0.00038	0.0113	CbGeAlD
Gefitinib—CYP1A1—liver—primary biliary cirrhosis	0.00036	0.0107	CbGeAlD
Gefitinib—CYP3A5—liver—primary biliary cirrhosis	0.000352	0.0105	CbGeAlD
Gefitinib—CYP2C9—liver—primary biliary cirrhosis	0.000347	0.0103	CbGeAlD
Gefitinib—ABCB1—epithelium—primary biliary cirrhosis	0.00033	0.00981	CbGeAlD
Gefitinib—CYP3A4—liver—primary biliary cirrhosis	0.000264	0.00785	CbGeAlD
Gefitinib—CYP2D6—liver—primary biliary cirrhosis	0.00026	0.00773	CbGeAlD
Gefitinib—Vandetanib—ALB—primary biliary cirrhosis	0.000255	0.0462	CrCbGaD
Gefitinib—ABCB1—liver—primary biliary cirrhosis	0.000187	0.00556	CbGeAlD
Gefitinib—ALB—Transmembrane transport of small molecules—NUP210—primary biliary cirrhosis	2.82e-05	0.000215	CbGpPWpGaD
Gefitinib—ABCB1—Transmembrane transport of small molecules—AQP4—primary biliary cirrhosis	2.82e-05	0.000215	CbGpPWpGaD
Gefitinib—IRAK4—Immune System—CD80—primary biliary cirrhosis	2.8e-05	0.000214	CbGpPWpGaD
Gefitinib—CSNK1E—Disease—NOS2—primary biliary cirrhosis	2.79e-05	0.000213	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—CDH5—primary biliary cirrhosis	2.77e-05	0.000211	CbGpPWpGaD
Gefitinib—MKNK1—Signaling Pathways—HIF1A—primary biliary cirrhosis	2.76e-05	0.000211	CbGpPWpGaD
Gefitinib—EGFR—Adaptive Immune System—CD40LG—primary biliary cirrhosis	2.75e-05	0.00021	CbGpPWpGaD
Gefitinib—MKNK1—Signaling Pathways—AGT—primary biliary cirrhosis	2.75e-05	0.00021	CbGpPWpGaD
Gefitinib—EGFR—Disease—NUP210—primary biliary cirrhosis	2.74e-05	0.000209	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—PDHX—primary biliary cirrhosis	2.72e-05	0.000207	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—MMP3—primary biliary cirrhosis	2.71e-05	0.000207	CbGpPWpGaD
Gefitinib—CSNK1E—Disease—CD80—primary biliary cirrhosis	2.71e-05	0.000207	CbGpPWpGaD
Gefitinib—ABCB1—Transmembrane transport of small molecules—ABCC2—primary biliary cirrhosis	2.7e-05	0.000206	CbGpPWpGaD
Gefitinib—IRAK1—Innate Immune System—TYK2—primary biliary cirrhosis	2.69e-05	0.000206	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—CXCR5—primary biliary cirrhosis	2.66e-05	0.000203	CbGpPWpGaD
Gefitinib—ALB—Metabolism—OGDH—primary biliary cirrhosis	2.62e-05	0.0002	CbGpPWpGaD
Gefitinib—ALB—Transmembrane transport of small molecules—ABCG2—primary biliary cirrhosis	2.62e-05	0.0002	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism of lipids and lipoproteins—CTGF—primary biliary cirrhosis	2.6e-05	0.000198	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—PDHX—primary biliary cirrhosis	2.57e-05	0.000196	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—CCL5—primary biliary cirrhosis	2.56e-05	0.000195	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—DLAT—primary biliary cirrhosis	2.55e-05	0.000195	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—ABCB4—primary biliary cirrhosis	2.55e-05	0.000195	CbGpPWpGaD
Gefitinib—ERBB3—Innate Immune System—NFKB1—primary biliary cirrhosis	2.52e-05	0.000193	CbGpPWpGaD
Gefitinib—IRAK1—Immune System—CD40LG—primary biliary cirrhosis	2.5e-05	0.000191	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—RPS6KB1—primary biliary cirrhosis	2.48e-05	0.000189	CbGpPWpGaD
Gefitinib—ABCB1—Transmembrane transport of small molecules—NUP210—primary biliary cirrhosis	2.47e-05	0.000189	CbGpPWpGaD
Gefitinib—EGFR—Signaling by NGF—NFKB1—primary biliary cirrhosis	2.46e-05	0.000188	CbGpPWpGaD
Gefitinib—MKNK1—Signaling Pathways—CD80—primary biliary cirrhosis	2.44e-05	0.000186	CbGpPWpGaD
Gefitinib—ERBB3—Adaptive Immune System—NFKB1—primary biliary cirrhosis	2.42e-05	0.000185	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—CXCL9—primary biliary cirrhosis	2.42e-05	0.000185	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—DLAT—primary biliary cirrhosis	2.41e-05	0.000184	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—ABCB4—primary biliary cirrhosis	2.41e-05	0.000184	CbGpPWpGaD
Gefitinib—ALB—Metabolism of lipids and lipoproteins—CTGF—primary biliary cirrhosis	2.37e-05	0.000181	CbGpPWpGaD
Gefitinib—IRAK4—Immune System—TYK2—primary biliary cirrhosis	2.36e-05	0.000181	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—OGDH—primary biliary cirrhosis	2.36e-05	0.00018	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—CXCL10—primary biliary cirrhosis	2.35e-05	0.000179	CbGpPWpGaD
Gefitinib—ALB—Metabolism—PDHX—primary biliary cirrhosis	2.34e-05	0.000179	CbGpPWpGaD
Gefitinib—ERBB3—Disease—HIF1A—primary biliary cirrhosis	2.34e-05	0.000178	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—OGDH—primary biliary cirrhosis	2.3e-05	0.000176	CbGpPWpGaD
Gefitinib—ABCB1—Transmembrane transport of small molecules—ABCG2—primary biliary cirrhosis	2.3e-05	0.000175	CbGpPWpGaD
Gefitinib—CSNK1E—Disease—TYK2—primary biliary cirrhosis	2.28e-05	0.000174	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—CXCL10—primary biliary cirrhosis	2.26e-05	0.000173	CbGpPWpGaD
Gefitinib—EGFR—Axon guidance—MMP9—primary biliary cirrhosis	2.25e-05	0.000172	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—ELMO1—primary biliary cirrhosis	2.24e-05	0.000171	CbGpPWpGaD
Gefitinib—ERBB3—Immune System—CD80—primary biliary cirrhosis	2.23e-05	0.00017	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism of lipids and lipoproteins—GGT1—primary biliary cirrhosis	2.22e-05	0.00017	CbGpPWpGaD
Gefitinib—ALB—Metabolism—DLAT—primary biliary cirrhosis	2.2e-05	0.000168	CbGpPWpGaD
Gefitinib—ALB—Metabolism—ABCB4—primary biliary cirrhosis	2.2e-05	0.000168	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—OGDH—primary biliary cirrhosis	2.17e-05	0.000165	CbGpPWpGaD
Gefitinib—EGFR—Disease—GOT2—primary biliary cirrhosis	2.16e-05	0.000165	CbGpPWpGaD
Gefitinib—EGFR—Immune System—CTLA4—primary biliary cirrhosis	2.15e-05	0.000164	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—OGDH—primary biliary cirrhosis	2.15e-05	0.000164	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—HIF1A—primary biliary cirrhosis	2.15e-05	0.000164	CbGpPWpGaD
Gefitinib—ABCG2—Metabolism—NUP210—primary biliary cirrhosis	2.14e-05	0.000164	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—MMP3—primary biliary cirrhosis	2.14e-05	0.000163	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—AGT—primary biliary cirrhosis	2.14e-05	0.000163	CbGpPWpGaD
Gefitinib—EGFR—Developmental Biology—MMP2—primary biliary cirrhosis	2.14e-05	0.000163	CbGpPWpGaD
Gefitinib—EGFR—Innate Immune System—CD80—primary biliary cirrhosis	2.13e-05	0.000163	CbGpPWpGaD
Gefitinib—EGFR—Signaling by GPCR—CXCL10—primary biliary cirrhosis	2.13e-05	0.000163	CbGpPWpGaD
Gefitinib—ERBB3—Disease—NOS2—primary biliary cirrhosis	2.12e-05	0.000162	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism of lipids and lipoproteins—CTGF—primary biliary cirrhosis	2.12e-05	0.000162	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—PDHX—primary biliary cirrhosis	2.1e-05	0.00016	CbGpPWpGaD
Gefitinib—IRAK1—Innate Immune System—NFKB1—primary biliary cirrhosis	2.1e-05	0.00016	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—MMP3—primary biliary cirrhosis	2.06e-05	0.000158	CbGpPWpGaD
Gefitinib—ERBB3—Disease—CD80—primary biliary cirrhosis	2.06e-05	0.000157	CbGpPWpGaD
Gefitinib—MKNK1—Signaling Pathways—TYK2—primary biliary cirrhosis	2.06e-05	0.000157	CbGpPWpGaD
Gefitinib—EGFR—Immune System—CD79A—primary biliary cirrhosis	2.05e-05	0.000157	CbGpPWpGaD
Gefitinib—EGFR—Adaptive Immune System—CD80—primary biliary cirrhosis	2.05e-05	0.000156	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—PDHX—primary biliary cirrhosis	2.05e-05	0.000156	CbGpPWpGaD
Gefitinib—EGFR—Developmental Biology—TYK2—primary biliary cirrhosis	2.04e-05	0.000156	CbGpPWpGaD
Gefitinib—ALB—Metabolism of lipids and lipoproteins—GGT1—primary biliary cirrhosis	2.02e-05	0.000155	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—CCL5—primary biliary cirrhosis	2.02e-05	0.000154	CbGpPWpGaD
Gefitinib—EGFR—Immune System—TAB1—primary biliary cirrhosis	2.01e-05	0.000154	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism of lipids and lipoproteins—PPARGC1A—primary biliary cirrhosis	1.98e-05	0.000151	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—ABCB4—primary biliary cirrhosis	1.97e-05	0.000151	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—DLAT—primary biliary cirrhosis	1.97e-05	0.000151	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—LBR—primary biliary cirrhosis	1.96e-05	0.00015	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—RPS6KB1—primary biliary cirrhosis	1.96e-05	0.00015	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—CCL5—primary biliary cirrhosis	1.95e-05	0.000149	CbGpPWpGaD
Gefitinib—EGFR—Signaling by GPCR—MMP3—primary biliary cirrhosis	1.94e-05	0.000149	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—primary biliary cirrhosis	1.94e-05	0.000148	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—PDHX—primary biliary cirrhosis	1.93e-05	0.000147	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—ABCB4—primary biliary cirrhosis	1.93e-05	0.000147	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—DLAT—primary biliary cirrhosis	1.93e-05	0.000147	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—PDHX—primary biliary cirrhosis	1.91e-05	0.000146	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—CD80—primary biliary cirrhosis	1.89e-05	0.000145	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—RPS6KB1—primary biliary cirrhosis	1.89e-05	0.000144	CbGpPWpGaD
Gefitinib—ERBB3—Immune System—TYK2—primary biliary cirrhosis	1.88e-05	0.000144	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—CXCL10—primary biliary cirrhosis	1.88e-05	0.000144	CbGpPWpGaD
Gefitinib—EGFR—Disease—GOT1—primary biliary cirrhosis	1.87e-05	0.000143	CbGpPWpGaD
Gefitinib—IRAK1—Immune System—CD80—primary biliary cirrhosis	1.86e-05	0.000142	CbGpPWpGaD
Gefitinib—IRAK4—Immune System—NFKB1—primary biliary cirrhosis	1.84e-05	0.000141	CbGpPWpGaD
Gefitinib—EGFR—Signaling by GPCR—CCL5—primary biliary cirrhosis	1.84e-05	0.00014	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism of lipids and lipoproteins—GGT1—primary biliary cirrhosis	1.82e-05	0.000139	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—ABCB4—primary biliary cirrhosis	1.82e-05	0.000139	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—DLAT—primary biliary cirrhosis	1.82e-05	0.000139	CbGpPWpGaD
Gefitinib—ALB—Metabolism of lipids and lipoproteins—PPARGC1A—primary biliary cirrhosis	1.8e-05	0.000138	CbGpPWpGaD
Gefitinib—EGFR—Innate Immune System—TYK2—primary biliary cirrhosis	1.8e-05	0.000138	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—ABCB4—primary biliary cirrhosis	1.8e-05	0.000137	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—DLAT—primary biliary cirrhosis	1.8e-05	0.000137	CbGpPWpGaD
Gefitinib—ERBB3—Disease—TYK2—primary biliary cirrhosis	1.74e-05	0.000133	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—MMP3—primary biliary cirrhosis	1.72e-05	0.000131	CbGpPWpGaD
Gefitinib—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—primary biliary cirrhosis	1.72e-05	0.000131	CbGpPWpGaD
Gefitinib—ABCG2—Metabolism—CTGF—primary biliary cirrhosis	1.71e-05	0.00013	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—HIF1A—primary biliary cirrhosis	1.7e-05	0.00013	CbGpPWpGaD
Gefitinib—ABCG2—Metabolism—GOT2—primary biliary cirrhosis	1.69e-05	0.000129	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—AGT—primary biliary cirrhosis	1.69e-05	0.000129	CbGpPWpGaD
Gefitinib—EGFR—Immune System—CD40LG—primary biliary cirrhosis	1.67e-05	0.000128	CbGpPWpGaD
Gefitinib—ABCG2—Transmembrane transport of small molecules—ALB—primary biliary cirrhosis	1.66e-05	0.000127	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism of lipids and lipoproteins—GGT1—primary biliary cirrhosis	1.66e-05	0.000127	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—HIF1A—primary biliary cirrhosis	1.64e-05	0.000125	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—AGT—primary biliary cirrhosis	1.63e-05	0.000124	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—CCL5—primary biliary cirrhosis	1.62e-05	0.000124	CbGpPWpGaD
Gefitinib—MKNK1—Signaling Pathways—MMP9—primary biliary cirrhosis	1.62e-05	0.000124	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism of lipids and lipoproteins—PPARGC1A—primary biliary cirrhosis	1.62e-05	0.000123	CbGpPWpGaD
Gefitinib—EGFR—Developmental Biology—MMP9—primary biliary cirrhosis	1.61e-05	0.000123	CbGpPWpGaD
Gefitinib—MKNK1—Signaling Pathways—NFKB1—primary biliary cirrhosis	1.6e-05	0.000122	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—TYK2—primary biliary cirrhosis	1.6e-05	0.000122	CbGpPWpGaD
Gefitinib—EGFR—Developmental Biology—NFKB1—primary biliary cirrhosis	1.59e-05	0.000121	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—RPS6KB1—primary biliary cirrhosis	1.57e-05	0.00012	CbGpPWpGaD
Gefitinib—IRAK1—Immune System—TYK2—primary biliary cirrhosis	1.57e-05	0.00012	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism of lipids and lipoproteins—AGT—primary biliary cirrhosis	1.54e-05	0.000118	CbGpPWpGaD
Gefitinib—EGFR—Signaling by GPCR—AGT—primary biliary cirrhosis	1.54e-05	0.000117	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—NUP210—primary biliary cirrhosis	1.53e-05	0.000117	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—CD80—primary biliary cirrhosis	1.5e-05	0.000114	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism of lipids and lipoproteins—PPARGC1A—primary biliary cirrhosis	1.47e-05	0.000113	CbGpPWpGaD
Gefitinib—ERBB3—Immune System—NFKB1—primary biliary cirrhosis	1.47e-05	0.000112	CbGpPWpGaD
Gefitinib—ABCG2—Metabolism—GOT1—primary biliary cirrhosis	1.46e-05	0.000112	CbGpPWpGaD
Gefitinib—ABCG2—Metabolism—GGT1—primary biliary cirrhosis	1.46e-05	0.000112	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—NUP210—primary biliary cirrhosis	1.45e-05	0.000111	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—CD80—primary biliary cirrhosis	1.44e-05	0.00011	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—ABCG2—primary biliary cirrhosis	1.43e-05	0.000109	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—OGDH—primary biliary cirrhosis	1.42e-05	0.000108	CbGpPWpGaD
Gefitinib—ALB—Hemostasis—NOS2—primary biliary cirrhosis	1.41e-05	0.000107	CbGpPWpGaD
Gefitinib—EGFR—Innate Immune System—NFKB1—primary biliary cirrhosis	1.4e-05	0.000107	CbGpPWpGaD
Gefitinib—ALB—Metabolism of lipids and lipoproteins—AGT—primary biliary cirrhosis	1.4e-05	0.000107	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—HIF1A—primary biliary cirrhosis	1.36e-05	0.000104	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—AGT—primary biliary cirrhosis	1.36e-05	0.000104	CbGpPWpGaD
Gefitinib—EGFR—Adaptive Immune System—NFKB1—primary biliary cirrhosis	1.35e-05	0.000103	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—ABCG2—primary biliary cirrhosis	1.35e-05	0.000103	CbGpPWpGaD
Gefitinib—ALB—Metabolism—NUP210—primary biliary cirrhosis	1.32e-05	0.000101	CbGpPWpGaD
Gefitinib—ABCG2—Metabolism—PPARGC1A—primary biliary cirrhosis	1.3e-05	9.93e-05	CbGpPWpGaD
Gefitinib—EGFR—Disease—HIF1A—primary biliary cirrhosis	1.3e-05	9.93e-05	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—TYK2—primary biliary cirrhosis	1.26e-05	9.65e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—PDHX—primary biliary cirrhosis	1.26e-05	9.64e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—CXCL10—primary biliary cirrhosis	1.26e-05	9.62e-05	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism of lipids and lipoproteins—AGT—primary biliary cirrhosis	1.26e-05	9.62e-05	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—MMP9—primary biliary cirrhosis	1.26e-05	9.62e-05	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—NFKB1—primary biliary cirrhosis	1.25e-05	9.51e-05	CbGpPWpGaD
Gefitinib—EGFR—Immune System—CD80—primary biliary cirrhosis	1.24e-05	9.49e-05	CbGpPWpGaD
Gefitinib—ALB—Metabolism—ABCG2—primary biliary cirrhosis	1.23e-05	9.38e-05	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—CTGF—primary biliary cirrhosis	1.22e-05	9.34e-05	CbGpPWpGaD
Gefitinib—IRAK1—Immune System—NFKB1—primary biliary cirrhosis	1.22e-05	9.34e-05	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—TYK2—primary biliary cirrhosis	1.22e-05	9.3e-05	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—GOT2—primary biliary cirrhosis	1.21e-05	9.26e-05	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—CD80—primary biliary cirrhosis	1.2e-05	9.18e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—ABCB4—primary biliary cirrhosis	1.19e-05	9.06e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—DLAT—primary biliary cirrhosis	1.19e-05	9.06e-05	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—NUP210—primary biliary cirrhosis	1.19e-05	9.06e-05	CbGpPWpGaD
Gefitinib—EGFR—Disease—NOS2—primary biliary cirrhosis	1.18e-05	9.03e-05	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism of lipids and lipoproteins—ALB—primary biliary cirrhosis	1.18e-05	9.02e-05	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—NUP210—primary biliary cirrhosis	1.16e-05	8.84e-05	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—CTGF—primary biliary cirrhosis	1.16e-05	8.83e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—MMP3—primary biliary cirrhosis	1.15e-05	8.77e-05	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism of lipids and lipoproteins—AGT—primary biliary cirrhosis	1.15e-05	8.77e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling by GPCR—TYK2—primary biliary cirrhosis	1.15e-05	8.77e-05	CbGpPWpGaD
Gefitinib—EGFR—Disease—CD80—primary biliary cirrhosis	1.15e-05	8.76e-05	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—GOT2—primary biliary cirrhosis	1.15e-05	8.75e-05	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—ABCG2—primary biliary cirrhosis	1.1e-05	8.42e-05	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—NUP210—primary biliary cirrhosis	1.09e-05	8.33e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—CCL5—primary biliary cirrhosis	1.08e-05	8.28e-05	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—NUP210—primary biliary cirrhosis	1.08e-05	8.26e-05	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—ABCG2—primary biliary cirrhosis	1.08e-05	8.22e-05	CbGpPWpGaD
Gefitinib—ALB—Metabolism—CTGF—primary biliary cirrhosis	1.05e-05	8.05e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—RPS6KB1—primary biliary cirrhosis	1.05e-05	8.02e-05	CbGpPWpGaD
Gefitinib—EGFR—Immune System—TYK2—primary biliary cirrhosis	1.05e-05	8.01e-05	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—GOT1—primary biliary cirrhosis	1.05e-05	7.99e-05	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—GGT1—primary biliary cirrhosis	1.05e-05	7.99e-05	CbGpPWpGaD
Gefitinib—ALB—Metabolism—GOT2—primary biliary cirrhosis	1.04e-05	7.98e-05	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—TYK2—primary biliary cirrhosis	1.01e-05	7.75e-05	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—ABCG2—primary biliary cirrhosis	1.01e-05	7.74e-05	CbGpPWpGaD
Gefitinib—ABCG2—Metabolism—AGT—primary biliary cirrhosis	1.01e-05	7.73e-05	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—ABCG2—primary biliary cirrhosis	1.01e-05	7.68e-05	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—MMP9—primary biliary cirrhosis	9.96e-06	7.6e-05	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—GGT1—primary biliary cirrhosis	9.89e-06	7.55e-05	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—GOT1—primary biliary cirrhosis	9.89e-06	7.55e-05	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—NFKB1—primary biliary cirrhosis	9.85e-06	7.52e-05	CbGpPWpGaD
Gefitinib—EGFR—Disease—TYK2—primary biliary cirrhosis	9.69e-06	7.4e-05	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism of lipids and lipoproteins—ALB—primary biliary cirrhosis	9.67e-06	7.38e-05	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—MMP9—primary biliary cirrhosis	9.6e-06	7.33e-05	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—NFKB1—primary biliary cirrhosis	9.49e-06	7.25e-05	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—CTGF—primary biliary cirrhosis	9.46e-06	7.22e-05	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—GOT2—primary biliary cirrhosis	9.38e-06	7.16e-05	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—PPARGC1A—primary biliary cirrhosis	9.32e-06	7.11e-05	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—CTGF—primary biliary cirrhosis	9.23e-06	7.05e-05	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—GOT2—primary biliary cirrhosis	9.15e-06	6.99e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—HIF1A—primary biliary cirrhosis	9.1e-06	6.95e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—AGT—primary biliary cirrhosis	9.07e-06	6.93e-05	CbGpPWpGaD
Gefitinib—ALB—Metabolism—GOT1—primary biliary cirrhosis	9.02e-06	6.88e-05	CbGpPWpGaD
Gefitinib—ALB—Metabolism—GGT1—primary biliary cirrhosis	9.02e-06	6.88e-05	CbGpPWpGaD
Gefitinib—ABCB1—Transmembrane transport of small molecules—ALB—primary biliary cirrhosis	8.97e-06	6.85e-05	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism of lipids and lipoproteins—ALB—primary biliary cirrhosis	8.81e-06	6.73e-05	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—PPARGC1A—primary biliary cirrhosis	8.8e-06	6.72e-05	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—CTGF—primary biliary cirrhosis	8.7e-06	6.64e-05	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—CTGF—primary biliary cirrhosis	8.63e-06	6.59e-05	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—GOT2—primary biliary cirrhosis	8.62e-06	6.59e-05	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—GOT2—primary biliary cirrhosis	8.55e-06	6.53e-05	CbGpPWpGaD
Gefitinib—EGFR—Immune System—NFKB1—primary biliary cirrhosis	8.17e-06	6.24e-05	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—GGT1—primary biliary cirrhosis	8.09e-06	6.18e-05	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—GOT1—primary biliary cirrhosis	8.09e-06	6.18e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—CD80—primary biliary cirrhosis	8.04e-06	6.14e-05	CbGpPWpGaD
Gefitinib—ALB—Metabolism—PPARGC1A—primary biliary cirrhosis	8.02e-06	6.13e-05	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—MMP9—primary biliary cirrhosis	7.99e-06	6.1e-05	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—NFKB1—primary biliary cirrhosis	7.9e-06	6.04e-05	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—GGT1—primary biliary cirrhosis	7.9e-06	6.03e-05	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—GOT1—primary biliary cirrhosis	7.9e-06	6.03e-05	CbGpPWpGaD
Gefitinib—ABCG2—Metabolism—ALB—primary biliary cirrhosis	7.77e-06	5.93e-05	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—GOT1—primary biliary cirrhosis	7.44e-06	5.68e-05	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—GGT1—primary biliary cirrhosis	7.44e-06	5.68e-05	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—GGT1—primary biliary cirrhosis	7.38e-06	5.64e-05	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—GOT1—primary biliary cirrhosis	7.38e-06	5.64e-05	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—AGT—primary biliary cirrhosis	7.26e-06	5.54e-05	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—PPARGC1A—primary biliary cirrhosis	7.2e-06	5.5e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—NUP210—primary biliary cirrhosis	7.13e-06	5.45e-05	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—PPARGC1A—primary biliary cirrhosis	7.03e-06	5.37e-05	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—AGT—primary biliary cirrhosis	6.86e-06	5.23e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—TYK2—primary biliary cirrhosis	6.78e-06	5.18e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—ABCG2—primary biliary cirrhosis	6.63e-06	5.06e-05	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—PPARGC1A—primary biliary cirrhosis	6.62e-06	5.06e-05	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—PPARGC1A—primary biliary cirrhosis	6.57e-06	5.01e-05	CbGpPWpGaD
Gefitinib—ALB—Metabolism—AGT—primary biliary cirrhosis	6.25e-06	4.77e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—CTGF—primary biliary cirrhosis	5.69e-06	4.34e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—GOT2—primary biliary cirrhosis	5.64e-06	4.31e-05	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—AGT—primary biliary cirrhosis	5.61e-06	4.28e-05	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—ALB—primary biliary cirrhosis	5.57e-06	4.25e-05	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—AGT—primary biliary cirrhosis	5.48e-06	4.18e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—MMP9—primary biliary cirrhosis	5.34e-06	4.08e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—NFKB1—primary biliary cirrhosis	5.29e-06	4.04e-05	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—ALB—primary biliary cirrhosis	5.26e-06	4.02e-05	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—AGT—primary biliary cirrhosis	5.16e-06	3.94e-05	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—AGT—primary biliary cirrhosis	5.12e-06	3.91e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—GGT1—primary biliary cirrhosis	4.87e-06	3.72e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—GOT1—primary biliary cirrhosis	4.87e-06	3.72e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—PPARGC1A—primary biliary cirrhosis	4.33e-06	3.31e-05	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—ALB—primary biliary cirrhosis	4.3e-06	3.29e-05	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—ALB—primary biliary cirrhosis	4.2e-06	3.21e-05	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—ALB—primary biliary cirrhosis	3.96e-06	3.02e-05	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—ALB—primary biliary cirrhosis	3.93e-06	3e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—AGT—primary biliary cirrhosis	3.37e-06	2.58e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—ALB—primary biliary cirrhosis	2.59e-06	1.98e-05	CbGpPWpGaD
